Structure Therapeutics, Inc. (GPCR)
67.88
-1.06
(-1.54%)
USD |
NASDAQ |
Dec 11, 15:06
Structure Therapeutics EPS Diluted (Quarterly): -1.125 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Pfizer Inc. | 0.6197 |
| Altimmune, Inc. | -0.2126 |
| Viking Therapeutics, Inc. | -0.8083 |
| Rhythm Pharmaceuticals, Inc. | -0.8192 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -65.80M |
| Total Expenses (Quarterly) | 65.80M |
| Enterprise Value | 3.179B |
| Earnings Yield | -5.38% |
| Normalized Earnings Yield | -5.381 |